ID   UGDH_HUMAN              Reviewed;         494 AA.
AC   O60701; B3KUU2; B4DN25; O60589;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   10-MAY-2017, entry version 162.
DE   RecName: Full=UDP-glucose 6-dehydrogenase;
DE            Short=UDP-Glc dehydrogenase;
DE            Short=UDP-GlcDH;
DE            Short=UDPGDH;
DE            EC=1.1.1.22;
GN   Name=UGDH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=9737970; DOI=10.1074/jbc.273.39.25117;
RA   Spicer A.P., Kaback L.A., Smith T.J., Seldin M.F.;
RT   "Molecular cloning and characterization of the human and mouse UDP-
RT   glucose dehydrogenase genes.";
RL   J. Biol. Chem. 273:25117-25124(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=9850599;
RA   Peng H.L., Lou M.D., Chang M.L., Chang H.Y.;
RT   "cDNA cloning and expression analysis of the human UDPglucose
RT   dehydrogenase.";
RL   Proc. Natl. Sci. Counc. Repub. China, B, Life Sci. 22:166-172(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Chang M.L., Chang H.Y., Peng H.L.;
RT   "Characterization of human gene encoding UDP-glucose dehydrogenase.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 214-388 (ISOFORM 1/2/3).
RA   Raghuram V., Foskett J.K.;
RL   Submitted (FEB-1998) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-107, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-476, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 1-466, AND ACTIVE SITE.
RX   PubMed=22123821; DOI=10.1074/jbc.M111.313015;
RA   Egger S., Chaikuad A., Klimacek M., Kavanagh K.L., Oppermann U.,
RA   Nidetzky B.;
RT   "Structural and kinetic evidence that catalytic reaction of human UDP-
RT   glucose 6-dehydrogenase involves covalent thiohemiacetal and thioester
RT   enzyme intermediates.";
RL   J. Biol. Chem. 287:2119-2129(2012).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS), SUBUNIT, ENZYME REGULATION, AND
RP   ALLOSTERIC REGULATION.
RX   PubMed=21961565; DOI=10.1021/bi201381e;
RA   Sennett N.C., Kadirvelraj R., Wood Z.A.;
RT   "Conformational flexibility in the allosteric regulation of human UDP-
RT   alpha-D-glucose 6-dehydrogenase.";
RL   Biochemistry 50:9651-9663(2011).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 1-466 IN COMPLEX WITH NAD;
RP   UDP-GLUCOSE AND UDP-GLUCURONATE, SUBUNIT, AND ACTIVE SITE.
RX   PubMed=21502315; DOI=10.1074/jbc.M111.234682;
RA   Egger S., Chaikuad A., Kavanagh K.L., Oppermann U., Nidetzky B.;
RT   "Structure and mechanism of human UDP-glucose 6-dehydrogenase.";
RL   J. Biol. Chem. 286:23877-23887(2011).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-487 IN COMPLEX WITH
RP   UDP-GLUCOSE, SUBUNIT, AND ACTIVE SITE.
RX   PubMed=21984906; DOI=10.1371/journal.pone.0025226;
RA   Rajakannan V., Lee H.S., Chong S.H., Ryu H.B., Bae J.Y., Whang E.Y.,
RA   Huh J.W., Cho S.W., Kang L.W., Choe H., Robinson R.C.;
RT   "Structural basis of cooperativity in human UDP-glucose
RT   dehydrogenase.";
RL   PLoS ONE 6:E25226-E25226(2011).
CC   -!- FUNCTION: Involved in the biosynthesis of glycosaminoglycans;
CC       hyaluronan, chondroitin sulfate, and heparan sulfate.
CC   -!- CATALYTIC ACTIVITY: UDP-glucose + 2 NAD(+) + H(2)O = UDP-
CC       glucuronate + 2 NADH.
CC   -!- ENZYME REGULATION: UDP-alpha-D-xylose (UDX) acts as a feedback
CC       inhibitor by activating an allosteric switch.
CC       {ECO:0000269|PubMed:21961565}.
CC   -!- PATHWAY: Nucleotide-sugar biosynthesis; UDP-alpha-D-glucuronate
CC       biosynthesis; UDP-alpha-D-glucuronate from UDP-alpha-D-glucose:
CC       step 1/1.
CC   -!- SUBUNIT: Homohexamer. {ECO:0000269|PubMed:21502315,
CC       ECO:0000269|PubMed:21961565, ECO:0000269|PubMed:21984906}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O60701-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60701-2; Sequence=VSP_042550;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=O60701-3; Sequence=VSP_046234;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:9850599}.
CC   -!- SIMILARITY: Belongs to the UDP-glucose/GDP-mannose dehydrogenase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF061016; AAC36095.1; -; mRNA.
DR   EMBL; AJ007702; CAA07609.1; -; mRNA.
DR   EMBL; AJ272274; CAB75891.1; -; Genomic_DNA.
DR   EMBL; AJ272275; CAB75891.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272276; CAB75891.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272277; CAB75891.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272278; CAB75891.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272279; CAB75891.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272280; CAB75891.1; JOINED; Genomic_DNA.
DR   EMBL; AJ272281; CAB75891.1; JOINED; Genomic_DNA.
DR   EMBL; AK097930; BAG53554.1; -; mRNA.
DR   EMBL; AK297737; BAG60087.1; -; mRNA.
DR   EMBL; AC021148; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471069; EAW92937.1; -; Genomic_DNA.
DR   EMBL; BC022781; AAH22781.1; -; mRNA.
DR   EMBL; AF049126; AAC05135.1; -; mRNA.
DR   CCDS; CCDS3455.1; -. [O60701-1]
DR   CCDS; CCDS54757.1; -. [O60701-3]
DR   CCDS; CCDS54758.1; -. [O60701-2]
DR   PIR; JE0353; JE0353.
DR   RefSeq; NP_001171629.1; NM_001184700.1. [O60701-2]
DR   RefSeq; NP_001171630.1; NM_001184701.1. [O60701-3]
DR   RefSeq; NP_003350.1; NM_003359.3. [O60701-1]
DR   UniGene; Hs.572518; -.
DR   PDB; 2Q3E; X-ray; 2.00 A; A/B/C/D/E/F/G/H/I/J/K/L=1-466.
DR   PDB; 2QG4; X-ray; 2.10 A; A/B/C/D/E/F/G/H=1-466.
DR   PDB; 3ITK; X-ray; 2.40 A; A/B/C/D/E/F=1-466.
DR   PDB; 3KHU; X-ray; 2.30 A; A/B/C/D/E/F=1-466.
DR   PDB; 3PRJ; X-ray; 3.10 A; A/B/C/D/E/F=1-494.
DR   PDB; 3PTZ; X-ray; 2.50 A; A/B/C/D/E/F=1-494.
DR   PDB; 3TDK; X-ray; 2.80 A; A/B/C/D/E/F/G/H/I/J/K/L=1-487.
DR   PDB; 3TF5; X-ray; 2.30 A; A/B/C=1-494.
DR   PDB; 4EDF; X-ray; 2.08 A; A/B/C/D=1-494.
DR   PDB; 4QEJ; X-ray; 2.65 A; A/B/C=1-494.
DR   PDB; 4RJT; X-ray; 2.70 A; A/B/C=1-494.
DR   PDB; 5TJH; X-ray; 2.05 A; A/B/C/D/E/F=1-494.
DR   PDBsum; 2Q3E; -.
DR   PDBsum; 2QG4; -.
DR   PDBsum; 3ITK; -.
DR   PDBsum; 3KHU; -.
DR   PDBsum; 3PRJ; -.
DR   PDBsum; 3PTZ; -.
DR   PDBsum; 3TDK; -.
DR   PDBsum; 3TF5; -.
DR   PDBsum; 4EDF; -.
DR   PDBsum; 4QEJ; -.
DR   PDBsum; 4RJT; -.
DR   PDBsum; 5TJH; -.
DR   ProteinModelPortal; O60701; -.
DR   SMR; O60701; -.
DR   BioGrid; 113205; 38.
DR   IntAct; O60701; 6.
DR   MINT; MINT-5000810; -.
DR   STRING; 9606.ENSP00000319501; -.
DR   DrugBank; DB00157; NADH.
DR   iPTMnet; O60701; -.
DR   PhosphoSitePlus; O60701; -.
DR   SwissPalm; O60701; -.
DR   BioMuta; UGDH; -.
DR   REPRODUCTION-2DPAGE; O60701; -.
DR   EPD; O60701; -.
DR   MaxQB; O60701; -.
DR   PaxDb; O60701; -.
DR   PeptideAtlas; O60701; -.
DR   PRIDE; O60701; -.
DR   DNASU; 7358; -.
DR   Ensembl; ENST00000316423; ENSP00000319501; ENSG00000109814. [O60701-1]
DR   Ensembl; ENST00000501493; ENSP00000422909; ENSG00000109814. [O60701-2]
DR   Ensembl; ENST00000506179; ENSP00000421757; ENSG00000109814. [O60701-1]
DR   Ensembl; ENST00000507089; ENSP00000426560; ENSG00000109814. [O60701-3]
DR   GeneID; 7358; -.
DR   KEGG; hsa:7358; -.
DR   UCSC; uc003guk.3; human. [O60701-1]
DR   CTD; 7358; -.
DR   DisGeNET; 7358; -.
DR   GeneCards; UGDH; -.
DR   HGNC; HGNC:12525; UGDH.
DR   HPA; CAB034444; -.
DR   HPA; HPA036656; -.
DR   HPA; HPA036657; -.
DR   MIM; 603370; gene.
DR   neXtProt; NX_O60701; -.
DR   OpenTargets; ENSG00000109814; -.
DR   PharmGKB; PA37170; -.
DR   eggNOG; KOG2666; Eukaryota.
DR   eggNOG; COG1004; LUCA.
DR   GeneTree; ENSGT00390000015355; -.
DR   HOGENOM; HOG000153773; -.
DR   HOVERGEN; HBG003512; -.
DR   InParanoid; O60701; -.
DR   KO; K00012; -.
DR   OMA; VIIMNDY; -.
DR   OrthoDB; EOG091G05RK; -.
DR   PhylomeDB; O60701; -.
DR   TreeFam; TF105671; -.
DR   BRENDA; 1.1.1.22; 2681.
DR   Reactome; R-HSA-173599; Formation of the active cofactor, UDP-glucuronate.
DR   SABIO-RK; O60701; -.
DR   UniPathway; UPA00038; UER00491.
DR   ChiTaRS; UGDH; human.
DR   EvolutionaryTrace; O60701; -.
DR   GeneWiki; UGDH; -.
DR   GenomeRNAi; 7358; -.
DR   PRO; PR:O60701; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000109814; -.
DR   CleanEx; HS_UGDH; -.
DR   ExpressionAtlas; O60701; baseline and differential.
DR   Genevisible; O60701; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0009055; F:electron carrier activity; TAS:UniProtKB.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0003979; F:UDP-glucose 6-dehydrogenase activity; TAS:Reactome.
DR   GO; GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl.
DR   GO; GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:ProtInc.
DR   GO; GO:0006011; P:UDP-glucose metabolic process; TAS:ProtInc.
DR   GO; GO:0006065; P:UDP-glucuronate biosynthetic process; TAS:Reactome.
DR   InterPro; IPR008927; 6-PGluconate_DH_C-like.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR017476; UDP-Glc/GDP-Man.
DR   InterPro; IPR014027; UDP-Glc/GDP-Man_DH_C.
DR   InterPro; IPR014026; UDP-Glc/GDP-Man_DH_dimer.
DR   InterPro; IPR001732; UDP-Glc/GDP-Man_DH_N.
DR   InterPro; IPR028356; UDPglc_DH_euk.
DR   Pfam; PF00984; UDPG_MGDP_dh; 1.
DR   Pfam; PF03720; UDPG_MGDP_dh_C; 1.
DR   Pfam; PF03721; UDPG_MGDP_dh_N; 1.
DR   PIRSF; PIRSF500133; UDPglc_DH_euk; 1.
DR   PIRSF; PIRSF000124; UDPglc_GDPman_dh; 1.
DR   SMART; SM00984; UDPG_MGDP_dh_C; 1.
DR   SUPFAM; SSF48179; SSF48179; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   SUPFAM; SSF52413; SSF52413; 1.
DR   TIGRFAMs; TIGR03026; NDP-sugDHase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allosteric enzyme; Alternative splicing;
KW   Complete proteome; NAD; Oxidoreductase; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN         1    494       UDP-glucose 6-dehydrogenase.
FT                                /FTId=PRO_0000074060.
FT   NP_BIND      11     16       NAD. {ECO:0000269|PubMed:21502315}.
FT   NP_BIND      89     93       NAD. {ECO:0000269|PubMed:21502315}.
FT   NP_BIND     130    131       NAD. {ECO:0000269|PubMed:21502315}.
FT   NP_BIND     276    279       NAD. {ECO:0000269|PubMed:21502315}.
FT   REGION      161    165       Substrate binding.
FT                                {ECO:0000305|PubMed:21502315}.
FT   REGION      220    224       Substrate binding.
FT                                {ECO:0000305|PubMed:21502315}.
FT   REGION      267    273       Substrate binding.
FT                                {ECO:0000305|PubMed:21502315}.
FT   REGION      338    339       Substrate binding.
FT                                {ECO:0000305|PubMed:21502315}.
FT   ACT_SITE    276    276       Nucleophile.
FT                                {ECO:0000269|PubMed:21502315,
FT                                ECO:0000269|PubMed:21984906,
FT                                ECO:0000269|PubMed:22123821}.
FT   BINDING      36     36       NAD. {ECO:0000269|PubMed:21502315}.
FT   BINDING      41     41       NAD. {ECO:0000269|PubMed:21502315}.
FT   BINDING     165    165       NAD. {ECO:0000269|PubMed:21502315}.
FT   BINDING     260    260       Substrate. {ECO:0000305|PubMed:21502315}.
FT   BINDING     346    346       NAD. {ECO:0000269|PubMed:21502315}.
FT   BINDING     442    442       Substrate. {ECO:0000305|PubMed:21502315}.
FT   MOD_RES     107    107       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     476    476       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1     97       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046234.
FT   VAR_SEQ      89    155       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042550.
FT   CONFLICT    338    338       F -> V (in Ref. 8; AAC05135).
FT                                {ECO:0000305}.
FT   CONFLICT    377    377       V -> A (in Ref. 8; AAC05135).
FT                                {ECO:0000305}.
FT   STRAND        6     10       {ECO:0000244|PDB:2Q3E}.
FT   HELIX        16     26       {ECO:0000244|PDB:2Q3E}.
FT   STRAND       30     35       {ECO:0000244|PDB:2Q3E}.
FT   HELIX        39     45       {ECO:0000244|PDB:2Q3E}.
FT   STRAND       47     49       {ECO:0000244|PDB:2Q3E}.
FT   HELIX        57     64       {ECO:0000244|PDB:2Q3E}.
FT   TURN         66     68       {ECO:0000244|PDB:2Q3E}.
FT   STRAND       69     73       {ECO:0000244|PDB:2Q3E}.
FT   HELIX        75     81       {ECO:0000244|PDB:2Q3E}.
FT   STRAND       83     87       {ECO:0000244|PDB:2Q3E}.
FT   STRAND       95     97       {ECO:0000244|PDB:3KHU}.
FT   TURN         98    102       {ECO:0000244|PDB:2Q3E}.
FT   HELIX       107    118       {ECO:0000244|PDB:2Q3E}.
FT   STRAND      122    128       {ECO:0000244|PDB:2Q3E}.
FT   HELIX       136    146       {ECO:0000244|PDB:2Q3E}.
FT   STRAND      153    158       {ECO:0000244|PDB:2Q3E}.
FT   HELIX       168    173       {ECO:0000244|PDB:2Q3E}.
FT   STRAND      178    181       {ECO:0000244|PDB:2Q3E}.
FT   HELIX       186    199       {ECO:0000244|PDB:2Q3E}.
FT   TURN        200    202       {ECO:0000244|PDB:2Q3E}.
FT   HELIX       205    207       {ECO:0000244|PDB:2Q3E}.
FT   STRAND      208    211       {ECO:0000244|PDB:2Q3E}.
FT   HELIX       213    244       {ECO:0000244|PDB:2Q3E}.
FT   HELIX       248    256       {ECO:0000244|PDB:2Q3E}.
FT   TURN        259    261       {ECO:0000244|PDB:2Q3E}.
FT   STRAND      263    265       {ECO:0000244|PDB:2Q3E}.
FT   STRAND      274    276       {ECO:0000244|PDB:2Q3E}.
FT   HELIX       277    290       {ECO:0000244|PDB:2Q3E}.
FT   HELIX       294    321       {ECO:0000244|PDB:2Q3E}.
FT   TURN        322    324       {ECO:0000244|PDB:2Q3E}.
FT   STRAND      330    334       {ECO:0000244|PDB:2Q3E}.
FT   STRAND      337    339       {ECO:0000244|PDB:2Q3E}.
FT   HELIX       349    359       {ECO:0000244|PDB:2Q3E}.
FT   STRAND      363    367       {ECO:0000244|PDB:2Q3E}.
FT   STRAND      369    371       {ECO:0000244|PDB:2Q3E}.
FT   HELIX       373    380       {ECO:0000244|PDB:2Q3E}.
FT   HELIX       390    394       {ECO:0000244|PDB:2Q3E}.
FT   STRAND      395    397       {ECO:0000244|PDB:2Q3E}.
FT   HELIX       401    405       {ECO:0000244|PDB:2Q3E}.
FT   STRAND      409    413       {ECO:0000244|PDB:2Q3E}.
FT   HELIX       418    422       {ECO:0000244|PDB:2Q3E}.
FT   HELIX       425    431       {ECO:0000244|PDB:2Q3E}.
FT   STRAND      437    442       {ECO:0000244|PDB:2Q3E}.
FT   TURN        444    447       {ECO:0000244|PDB:2Q3E}.
FT   HELIX       449    455       {ECO:0000244|PDB:2Q3E}.
FT   STRAND      458    461       {ECO:0000244|PDB:2Q3E}.
SQ   SEQUENCE   494 AA;  55024 MW;  9C9DA5E1227D65CC CRC64;
     MFEIKKICCI GAGYVGGPTC SVIAHMCPEI RVTVVDVNES RINAWNSPTL PIYEPGLKEV
     VESCRGKNLF FSTNIDDAIK EADLVFISVN TPTKTYGMGK GRAADLKYIE ACARRIVQNS
     NGYKIVTEKS TVPVRAAESI RRIFDANTKP NLNLQVLSNP EFLAEGTAIK DLKNPDRVLI
     GGDETPEGQR AVQALCAVYE HWVPREKILT TNTWSSELSK LAANAFLAQR ISSINSISAL
     CEATGADVEE VATAIGMDQR IGNKFLKASV GFGGSCFQKD VLNLVYLCEA LNLPEVARYW
     QQVIDMNDYQ RRRFASRIID SLFNTVTDKK IAILGFAFKK DTGDTRESSS IYISKYLMDE
     GAHLHIYDPK VPREQIVVDL SHPGVSEDDQ VSRLVTISKD PYEACDGAHA VVICTEWDMF
     KELDYERIHK KMLKPAFIFD GRRVLDGLHN ELQTIGFQIE TIGKKVSSKR IPYAPSGEIP
     KFSLQDPPNK KPKV
//
